Journal article

Sustainable implementation of innovative, technology-based health care practices: A qualitative case study from stroke telemedicine

Kathleen L Bagot, Natasha Moloczij, Karen Barclay-Moss, Michelle Vu, Christopher F Bladin, Dominique A Cadilhac

Journal of Telemedicine and Telecare | SAGE PUBLICATIONS LTD | Published : 2020

Abstract

Introduction Technology-based innovation requires long-term changes to workforce routines, otherwise practices will not be sustained. The aim of this study was to identify influential factors in the ongoing use of an acute stroke telemedicine programme. Methods A new acute stroke telemedicine programme in a regional hospital receiving 375 patients with stroke or transient ischaemic attack per year was used as an exploratory case study. Semi-structured interviews with acute care and emergency department clinicians ( n = 25) were conducted at two time-points: after a six-month pilot and then after a further 12-month implementation phase. Interviews (between 12-60 min) were recorded, transcribe..

View full abstract

Grants

Awarded by National Health and Medical Research Council/National Heart Foundation


Funding Acknowledgements

The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: Funding bodies had no role in the design of the study and collection, analysis and interpretation of data or writing of the manuscript. This project has been supported through funding from the Windermere Foundation, The State Government of Victoria: Department of Business and Innovation and Department of Health; and The Florey Institute of Neuroscience and Mental Health, University of Melbourne. The Florey Institute of Neuroscience and Mental Health acknowledges the strong support from the Victorian Government and in particular the funding from the Operational Infrastructure Support Grant. DA Cadilhac holds a National Health and Medical Research Council/National Heart Foundation research fellowship (1063761). CF Bladin and DA Cadilhac have received restricted educational grants from Boehringer Ingelheim.